Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:10 AM
Ignite Modification Date:
2025-12-25 @ 3:10 AM
NCT ID:
NCT02998905
Eligibility Criteria:
Inclusion Criteria:
* Previous primary intracerebral hemorrhage
* Atrial fibrillation (CHADS2 ≥ 2)
Exclusion Criteria:
* Non-stroke indication for antiplatelet or anticoagulant therapy
* Recent intracerebral hemorrhage within 14 days
* Platelet count less than 100,000/mm3 at enrollment or other bleeding diathesis
* Prior symptomatic lobar intracerebral hemorrhage other than the qualifying event
* Uncontrollable hypertension consistently above SBP/DBP of 160/100 mmHg
* Known hypersensitivity to either ASA or NOACs
* Inability to adhere to study procedures
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
45 Years
Study:
NCT02998905
Study Brief:
Protocol Section:
NCT02998905